Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia

Thumbnail
View/ Open

Show full item record
Author
McCubrey, James A.
URI
http://hdl.handle.net/10342/9587
Subject
 T-acute lymphoblastic leukemia; Perifosine; small molecules inhibitors (SMI) 
Date
2015-03-02
Citation:
APA:
McCubrey, James A.. (March 2015). Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia. , (), - . Retrieved from http://hdl.handle.net/10342/9587

Display/Hide MLA, Chicago and APA citation formats.

MLA:
McCubrey, James A.. "Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia". . . (), March 2015. September 27, 2023. http://hdl.handle.net/10342/9587.
Chicago:
McCubrey, James A., "Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia," , no. (March 2015), http://hdl.handle.net/10342/9587 (accessed September 27, 2023).
AMA:
McCubrey, James A.. Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia. . March 2015; (): . http://hdl.handle.net/10342/9587. Accessed September 27, 2023.
Collections